Statistics about Health, Pharma & Medtech in United States
Statistics
- Stem Holdings, Inc. gross profit 2018-2022
- Stem Holdings, Inc. revenue 2018-2022
- Statera Biopharma, Inc. revenue 2011-2021
- Sorrento Therapeutics revenue 2018-2022
- Stem Holdings, Inc. net income 2019-2023
- Statera Biopharma, Inc. net income 2017-2021
- Sorrento Therapeutics net income 2018-2022
- Springworks Therapeutics net income 2018-2020
- Ardelyx gross profit 2015-2019
- Ardelyx net income 2016-2020
- Hst Global net income 2019-2023
- Heska Corp revenue 2018-2022
- Heska Corp net income 2018-2022
- Harrow net income 2018-2021
- Solid Biosciences revenue 2018-2022
- Sonnet Biotherapeutics Holdings, Inc. net income 2015-2019
- Sunset Island Group total equity 2016-2017
- Alpine Immune Sciences net cash 2019-2023
- Alpine Immune Sciences operating profit 2019-2023
- Alpine Immune Sciences revenue 2019-2023
- Humanigen, Inc total equity 2018-2022
- Alimera Sciences total equity 2019-2023
- Alimera Sciences net cash 2019-2023
- Humanigen, Inc net cash 2018-2022
- Alimera Sciences operating profit 2019-2023
- Humanigen, Inc revenue 2020-2022
- Alimera Sciences gross profit 2019-2023
- Humanigen, Inc operating profit 2018-2022
- Alx Oncology Holdings revenue 2018-2022
- Societal Cdmo total equity 2019-2023
- Societal Cdmo net cash 2017-2023
- Societal Cdmo operating profit 2019-2023
- Societal Cdmo revenue 2019-2023
- Societal Cdmo net income 2019-2023
- Genocea Biosciences total equity 2017-2021
- Genocea Biosciences net cash 2018-2021
- Genocea Biosciences operating profit 2017-2021
- Genocea Biosciences revenue 2019-2021
- Spyre Therapeutics, Inc. net income 2018-2022
- Generex Biotechnology total equity 2016-2020
- Generex Biotechnology net cash 2016-2020
- Generex Biotechnology operating profit 2016-2020
- Generex Biotechnology net income 2011-2015
- Generex Biotechnology revenue 2018-2019
- Generex Biotechnology gross profit 2011-2020
- Satsuma Pharmaceuticals, Inc. total equity 2018-2022
- Satsuma Pharmaceuticals, Inc. net cash 2018-2022
- Satsuma Pharmaceuticals, Inc. operating profit 2018-2022
- Savara revenue 2015-2020
- Global Wholehealth Partners Corp total equity 2018-2022
- Global Wholehealth Partners Corp net cash 2019-2022
- Global Wholehealth Partners Corp operating profit 2019-2022
- Global Wholehealth Partners Corp revenue 2020-2022
- Global Wholehealth Partners Corp gross profit 2020-2022
- Globestar Therapeutics Corp total equity 2019-2023
- Globestar Therapeutics Corp net cash 2019-2023
- Globestar Therapeutics Corp gross profit 2017-2021
- Globestar Therapeutics Corp operating profit 2019-2023
- Globestar Therapeutics Corp revenue 2014-2020
- Gritstone Bio total equity 2019-2023
- Gritstone Bio net cash 2019-2023
- Gritstone Bio revenue 2019-2023
- Gritstone Bio operating profit 2019-2023
- Geron revenue 2019-2023
- Scholar Rock Holding revenue 2018-2022
- Satsuma Pharmaceuticals, Inc. net income 2018-2022
- Sibannac total equity 2012-2016
- Greenlight Biosciences Holdings, Pbc total equity 2020-2022
- Greenlight Biosciences Holdings, Pbc net cash 2021-2022
- Greenlight Biosciences Holdings, Pbc revenue 2021-2022
- Greenlight Biosciences Holdings, Pbc net income 2021-2022
- Greenlight Biosciences Holdings, Pbc operating profit 2021-2022
- Gain Therapeutics revenue 2020-2023
- Sibannac net cash 2012-2016
- Guardion Health Sciences total equity 2019-2023
- Guardion Health Sciences net cash 2019-2023
- Guardion Health Sciences operating profit 2019-2023
- Guardion Health Sciences revenue 2019-2023
- Guardion Health Sciences gross profit 2019-2023
- G1 Therapeutic total equity 2019-2023
- G1 Therapeutic net cash 2019-2023
- G1 Therapeutic operating profit 2019-2023
- G1 Therapeutic net income 2019-2023
- G1 Therapeutic revenue 2020-2023
- Gelesis Holdings total equity 2019-2022
- Sibannac operating profit 2015-2016
- Gelesis Holdings net cash 2020-2022
- Gelesis Holdings net income 2020-2022
- Gelesis Holdings operating profit 2020-2022
- Gelesis Holdings revenue 2021-2022
- Poseida Therapeutics operating profit 2019-2023
- Glucose Health total equity 2012-2016
- Glucose Health net cash 2012-2016
- Provention Bio, Inc. operating profit 2018-2022
- Glucose Health operating profit 2012-2016
- Glucose Health gross profit 2010-2016
- Glucose Health net income 2012-2013
- Sibannac gross profit 2012-2016
- Q Biomed gross profit 2020-2022
- Sibannac revenue 2012-2016